Literature DB >> 17581680

Recombinant E2 glycoprotein of bovine viral diarrhea virus induces a solid humoral neutralizing immune response but fails to confer total protection in cattle.

S Chimeno Zoth1, M R Leunda, A Odeón, O Taboga.   

Abstract

Two recombinant baculoviruses were produced in order to obtain a bovine viral diarrhea virus (BVDV) immunogen: AcNPV/E2 expressing E2 glycoprotein, and AcNPV/E0E1E2 expressing the polyprotein region coding for the three structural proteins of BVDV (E0, E1, and E2). Mice were immunized with Sf9 cells infected with the recombinant baculoviruses in a water in oil formulation and the production of neutralizing antibodies was evaluated. Since E2 elicited higher neutralizing antibody titers than E0-E1-E2 polyprotein, it was selected to immunize cattle. Calves received two doses of recombinant E2 vaccine and were challenged with homologous BVDV 37 days later. The recombinant immunogen induced neutralizing titers which showed a mean value of 1.5 +/- 0.27 on the day of challenge and reached a top value of 3.36 +/- 0.36, 47 days later (84 days post-vaccination). On the other hand, sera from animals which received mock-infected Sf9 cells did not show neutralizing activity until 25 days post-challenge (62 days post-vaccination), suggesting that these antibodies were produced as a consequence of BVDV challenge. Even when no total protection was observed in cattle, in vitro viral neutralization assays revealed that the recombinant immunogen was able to induce neutralizing antibody synthesis against the homologous strain as well as against heterologous strains in a very efficient way.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17581680     DOI: 10.1590/s0100-879x2007000600010

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  3 in total

1.  Safety and efficacy of an E2 glycoprotein subunit vaccine produced in mammalian cells to prevent experimental infection with bovine viral diarrhoea virus in cattle.

Authors:  Andrea Pecora; María Sol Pérez Aguirreburualde; Alejandra Aguirreburualde; Maria Rosa Leunda; Anselmo Odeon; Sebastián Chiavenna; Diego Bochoeyer; Marcelo Spitteler; Jorge L Filippi; Maria J Dus Santos; Susana M Levy; Andrés Wigdorovitz
Journal:  Vet Res Commun       Date:  2012-05-26       Impact factor: 2.459

2.  Mosaic Bovine Viral Diarrhea Virus Antigens Elicit Cross-Protective Immunity in Calves.

Authors:  Neha Sangewar; Wisam Hassan; Shehnaz Lokhandwala; Jocelyn Bray; Rachel Reith; Mary Markland; Huldah Sang; Jianxiu Yao; Bailey Fritz; Suryakant D Waghela; Karim W Abdelsalam; Christopher C L Chase; Waithaka Mwangi
Journal:  Front Immunol       Date:  2020-11-12       Impact factor: 7.561

Review 3.  Bovine Pestivirus Heterogeneity and Its Potential Impact on Vaccination and Diagnosis.

Authors:  Victor Riitho; Rebecca Strong; Magdalena Larska; Simon P Graham; Falko Steinbach
Journal:  Viruses       Date:  2020-10-06       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.